| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 681684 | 2-Trifluoroethoxy-6-oxoestra-1,3,5(10)-trien-3,17.beta.-diol | 0.00336064452966826 | 0.51154831 |
| NSC 710904 | Null | 0.00336064452966826 | 0.34566059 |
| NSC 329277 | Null | 0.00337662564965909 | 0.20840328 |
| NSC 633021 | Null | 0.00337662564965909 | 0.33365088 |
| NSC 672304 | Null | 0.00337662564965909 | 0.27947003 |
| NSC 685285 | Null | 0.00337662564965909 | 0.21774226 |
| NSC 719667 | 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one | 0.00337662564965909 | 0.2891236 |
| NSC 730009 | cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline | 0.00337662564965909 | 0.24936497 |
| NSC 748147 | 5-methyl-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide | 0.00337662564965909 | 0.35931229 |
| NSC 221266 | Benzoic acid, 3,4-dichloro-, [1-[4-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]ethylidene]hydrazide, monohy | 0.00366577979610622 | 0.31178151 |